Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A non-IMiD multi-target degrader reactivates fetal hemoglobin.

Created on 12 Nov 2026

Authors

Jun Liu, Ziyang Shen, Shin-Young Park, Yanhua Dong, Na Yu, Jing Zeng, Hannah Lee, Braden Pate, Sophia Adamia, Kim Vanuytsel, Junyan Zhang, Shang-Chuen Wu, Adelaide Herman, Shiva Moein, Wenhui Li, Miao Liu, Chong Gao, Xi Tian, Zhaoji Liu, Junsu Kwon, Kunhua Qin, Christoph Budjan, Claire Shao, Jiajia Li, Ernie Lee, Sanjana Arji, Bee-Hui Liu, Sean Stowell, John P Manis, David Justus, Gerd A Blobel, Hongbo R Luo, Roger Belizaire, Yi Zheng, Sahand Hormoz, Mahmoud A Bassal, Sarah Nikiforow, Jose A Cancelas, Daniel E Bauer, Daniel G Tenen, Li Chai

Published in

Experimental hematology & oncology. Volume 15. Issue 1. Nov 11, 2026. Epub Nov 11, 2026.

Abstract

Reactivation of fetal hemoglobin (HbF) is a validated therapeutic strategy for sickle cell disease (SCD) and β-thalassemia. Cereblon (CRBN)-dependent molecular-glue degraders of HbF repressors are advancing clinically, but all share an immunomodulatory imide drug (IMiD) backbone and its class liabilities. We show that SH6, a non-IMiD small-molecule degrader, consistently induces HbF in erythroid cell lines, primary healthy-donor, SCD, and β-thalassemia CD34⁺-derived erythroid cells, and humanized NBSGW mice, at nanomolar to low-micromolar concentrations. When all compounds were tested at a matched 0.25µM concentration, HbF induction by SH6 was comparable to that of decitabine and greater than that of hydroxyurea, pomalidomide or thalidomide. HbF induction is CRBN/proteasome-dependent and associated with simultaneous degradation of the γ-globin repressors ZBTB7A and BCL11A. These findings provide proof of concept for IMiD-independent pharmacologic HbF reactivation and support further study of SH6 as a mechanistically distinct tool compound.

PMID:
43015919
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement